protein
| binding to BPTF |
|
acting as a negative regulator of NFE2L2 which modulates NFE2L2 activity through a variety of proposed mechanisms (could sequester NFE2L2 in the cytosol and prevent its nuclear localization and activation of ARE-regulated genes) |
|
PGAM5, is a novel substrate for KEAP1  |
|
degrades endogenous antiapoptotic B-cell CLL/lymphoma 2 (BCL2) protein and controls cellular apoptosis |
|
KPNA6 directly interacts with the Kelch domain of KEAP1  |
|
AMER1 and NFE2L2 compete for binding to KEAP1, and thus loss of AMER1 leads to rapid ubiquitination and degradation of NFE2L2 and a reduced response to cytotoxic insult  |
|
NFE2L2 interacts with KEAP1, in the cytoplasm  |
|
PALB2 directly interacts with KEAP1, an oxidative stress sensor that binds and represses the master antioxidant transcription factor NFE2L2  |
|
KEAP1 targets and binds to NFE2L2 for proteosomal degradation  |
|
under unstressed conditions, serves as an adaptor for ubiquitin E3 ligase and promotes proteasomal degradation of NFE2L2, but NFE2L2 is stabilized when KEAP1 is inactivated under oxidative/electrophilic stress conditions  |
|
SESN1 and SESN2 interact with the NFE2L2 suppressor KEAP1, the autophagy substrate SQSTM1, and the ubiquitin ligase RBX1 and the antioxidant function of SESNs is mediated through activation of NFE2L2 in a manner reliant on SQSTM1-dependent autophagic degradation of KEAP1  |
|
AMER1, PALB2, and SQSTM1 bind KEAP1 to activate NFE2L2  |
|
USP15, specifically deubiquitinates KEAP1, which suppresses the NFE2L2 pathway  |
|
NTRK2 plays a key role in regulation of the tumor suppressors RUNX3 and KEAP1  |
|
PSMD10 interact with the Kelch domain of KEAP1 and effectively competed with NFE2L2 for KEAP1 binding  |
|
PGAM5 might participate in the degradation of BCL2L1 mediated by KEAP1  |
|
depletion of NFE2L2 or PGAM5, but not KEAP1, inhibits mitochondrial retrograde trafficking induced by proteasome inhibition  |
|
NIBAN2 induces NFE2L2 by competing for Kelch-like ECH-associated protein 1 (KEAP1) binding (the negative regulator of NFE2L2) via an ETGE motif  |